Dyne Therapeutics OverviewDyne Therapeutics Other Income Expense Net
Other Income/Expense Net for DYN.
Quarterly Other Income/Expense
$4.42M
↓ 36.93% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$19.38M
↓ 35.33% YoY
Trailing 12 months ending Mar 31, 2026